Annals of Medicine
Volume 55, 2023 - Issue 1
Open access
1,418
Views
2
CrossRef citations to date
0
Altmetric
Hematology
Avatrombopag, a promising novel thrombopoietin receptor agonist for refractory/relapsed/intolerant non-severe aplastic anemia: a phase 2 single-arm clinical trial
Ziqi Wana Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, P.R. China;b Peking Union Medical College, Beijing, P.R. ChinaView further author information
, Miao Chena Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, P.R. ChinaView further author information
& Bing Hana Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, P.R. ChinaCorrespondence[email protected]
View further author information
View further author information
Article: 2224044
|
Received 06 Jun 2022, Accepted 03 Jun 2023, Published online: 15 Jun 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.